Bruce D. Dorsey
ScholarGPS® ID: 27900396226905
Affiliation History
Discipline
Chemistry
Top Specialties
Medicinal Chemistry | HIV | HIV-1 Protease | Lymphoma | Chemical Synthesis | HIV/AIDS | Cancer | Protein Kinase | Protein Kinase Inhibitor | Oral Administration
Metrics Summary
Publication Count
99
Predicted Citations
4,966
Predicted h-index
33
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Journal of Medicinal Chemistry, volume 67, issue 2, pages 1421-1446 (2024). |
Bioorganic & Medicinal Chemistry Letters, volume 94 (2023). |
RSC Medicinal Chemistry, volume 13, issue 3, pages 343-349 (2022). |
Laboratory Notebooks and Data Storage (journal article) Current Protocols Essential Laboratory Techniques, volume 20, issue 1 (2020). |
Patent Number: 10414763 (2019) |
Patent Number: 10183950 (2019) |
Patent Number: 9914730 (2018) |
Patent Number: 9902696 (2018) |
Patent Number: 9896446 (2018) |
Patent Number: 9604994 (2017) |
Patent Number: 9487529 (2016) |
Patent Number: 9475766 (2016) |
Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK) (journal article) Journal of Medicinal Chemistry, volume 59, issue 16, pages 7478-7496 (2016). |
Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo[2,1-f][1,2,4]triazine as inhibitors of anaplastic lymphoma kinase (journal article) Bioorganic & Medicinal Chemistry Letters, volume 25, issue 5, pages 1047-1052 (2015). |
Design, Synthesis, and Biological Evaluation of Sulfonyl Acrylonitriles as Novel Inhibitors of Cancer Metastasis and Spread (journal article) Journal of Medicinal Chemistry, volume 58, issue 3, pages 1140-1158 (2015). |
Expert Opinion on Therapeutic Patents, volume 24, issue 4, pages 417-442 (2014). |
Patent Number: 8633173 (2014) |
Patent Number: 8552186 (2013) |
Patent Number: 8501936 (2013) |
A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5- a ]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779 (journal article) Journal of Medicinal Chemistry, volume 55, issue 11, pages 5243-5254 (2012). |